| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 1.296 | 3.791 | 4.918 | 7.356 | 8.475 | 12.527 |
| Total Income - EUR | - | - | - | - | 1.296 | 3.791 | 4.918 | 7.356 | 8.475 | 12.527 |
| Total Expenses - EUR | - | - | - | - | 1.170 | 796 | 2.341 | 3.882 | 1.776 | 1.918 |
| Gross Profit/Loss - EUR | - | - | - | - | 126 | 2.995 | 2.578 | 3.475 | 6.700 | 10.609 |
| Net Profit/Loss - EUR | - | - | - | - | 87 | 2.888 | 2.430 | 3.254 | 5.649 | 8.946 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Onco-Neonat S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 1.479 | 1.460 | 598 | 123 | 684 |
| Current Assets | - | - | - | - | 318 | 1.578 | 3.030 | 4.666 | 5.976 | 13.684 |
| Inventories | - | - | - | - | 151 | 0 | 0 | 0 | 485 | 0 |
| Receivables | - | - | - | - | 105 | 862 | 300 | 71 | 428 | 7.165 |
| Cash | - | - | - | - | 61 | 716 | 2.730 | 4.595 | 5.063 | 6.519 |
| Shareholders Funds | - | - | - | - | 129 | 3.015 | 4.359 | 5.065 | 5.698 | 8.994 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 189 | 42 | 131 | 199 | 401 | 5.374 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Onco-Neonat S.r.l.